<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25799064</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Mar</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family.</ArticleTitle><Pagination><StartPage>e1004733</StartPage><MedlinePgn>e1004733</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1004733</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1004733</ELocationID><Abstract><AbstractText>The genus Enterovirus of the family Picornaviridae contains many important human pathogens (e.g., poliovirus, coxsackievirus, rhinovirus, and enterovirus 71) for which no antiviral drugs are available. The viral RNA-dependent RNA polymerase is an attractive target for antiviral therapy. Nucleoside-based inhibitors have broad-spectrum activity but often exhibit off-target effects. Most non-nucleoside inhibitors (NNIs) target surface cavities, which are structurally more flexible than the nucleotide-binding pocket, and hence have a more narrow spectrum of activity and are more prone to resistance development. Here, we report a novel NNI, GPC-N114 (2,2'-[(4-chloro-1,2-phenylene)bis(oxy)]bis(5-nitro-benzonitrile)) with broad-spectrum activity against enteroviruses and cardioviruses (another genus in the picornavirus family). Surprisingly, coxsackievirus B3 (CVB3) and poliovirus displayed a high genetic barrier to resistance against GPC-N114. By contrast, EMCV, a cardiovirus, rapidly acquired resistance due to mutations in 3Dpol. In vitro polymerase activity assays showed that GPC-N114 i) inhibited the elongation activity of recombinant CVB3 and EMCV 3Dpol, (ii) had reduced activity against EMCV 3Dpol with the resistance mutations, and (iii) was most efficient in inhibiting 3Dpol when added before the RNA template-primer duplex. Elucidation of a crystal structure of the inhibitor bound to CVB3 3Dpol confirmed the RNA-binding channel as the target for GPC-N114. Docking studies of the compound into the crystal structures of the compound-resistant EMCV 3Dpol mutants suggested that the resistant phenotype is due to subtle changes that interfere with the binding of GPC-N114 but not of the RNA template-primer. In conclusion, this study presents the first NNI that targets the RNA template channel of the picornavirus polymerase and identifies a new pocket that can be used for the design of broad-spectrum inhibitors. Moreover, this study provides important new insight into the plasticity of picornavirus polymerases at the template binding site.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Linden</LastName><ForeName>Lonneke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands; Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vives-Adri&#xe1;n</LastName><ForeName>Laia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institut de Biologia Molecular de Barcelona (CSIC), Parc Cient&#xed;fic de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selisko</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>AFMB UMR 7257, Aix-Marseille Universit&#xe9; &amp; CNRS, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrer-Orta</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institut de Biologia Molecular de Barcelona (CSIC), Parc Cient&#xed;fic de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xinran</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Pennsylvania State University, University Park, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanke</LastName><ForeName>Kjerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulferts</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands; Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Palma</LastName><ForeName>Armando M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanchis</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Abteilung Pharmazeutische Chemie, Institut f&#xfc;r Pharmazie, Universit&#xe4;t Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goris</LastName><ForeName>Nesya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Okapi Sciences NV, Heverlee, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lefebvre</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Unit of Vesicular and Exotic Diseases, Virology Department, CODA-CERVA, Veterinary and Agrochemical Research Centre, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Clercq</LastName><ForeName>Kris</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Unit of Vesicular and Exotic Diseases, Virology Department, CODA-CERVA, Veterinary and Agrochemical Research Centre, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leyssen</LastName><ForeName>Pieter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacroix</LastName><ForeName>C&#xe9;line</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xfc;rstinger</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Abteilung Pharmazeutische Chemie, Institut f&#xfc;r Pharmazie, Universit&#xe4;t Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coutard</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>AFMB UMR 7257, Aix-Marseille Universit&#xe9; &amp; CNRS, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canard</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>AFMB UMR 7257, Aix-Marseille Universit&#xe9; &amp; CNRS, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boehr</LastName><ForeName>David D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Pennsylvania State University, University Park, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Jamie J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cameron</LastName><ForeName>Craig E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verdaguer</LastName><ForeName>Nuria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institut de Biologia Molecular de Barcelona (CSIC), Parc Cient&#xed;fic de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neyts</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Kuppeveld</LastName><ForeName>Frank J M</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands; Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>4Y2A</AccessionNumber><AccessionNumber>4Y34</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI104878</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber><NameOfSubstance UI="D012324">RNA-Dependent RNA Polymerase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017943" MajorTopicYN="N">Cardiovirus</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012324" MajorTopicYN="N">RNA-Dependent RNA Polymerase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>3</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25799064</ArticleId><ArticleId IdType="pmc">PMC4370873</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1004733</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-14-02401</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tapparel C, Siegrist F, Petty TJ, Kaiser L (2012) Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol.</Citation><ArticleIdList><ArticleId IdType="pubmed">23201849</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles NJ, Hovi T, Hyypi&#xe4; T, King AMQ, Lindberg AM, et al. (2012) Picornaviridae In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ, editors. Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses. San Diego: Elsevier; pp. 855&#x2013;880.</Citation></Reference><Reference><Citation>Appleby TC, Luecke H, Shim JH, Wu JZ, Cheney IW, Zhong W, Vogeley L, Hong Z, Yao N (2005) Crystal structure of complete rhinovirus RNA polymerase suggests front loading of protein primer. J Virol 79: 277&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538717</ArticleId><ArticleId IdType="pubmed">15596823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Orta C, Arias A, Perez-Luque R, Escarmis C, Domingo E, Verdaguer N (2004) Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA. J Biol Chem 279: 47212&#x2013;47221.</Citation><ArticleIdList><ArticleId IdType="pubmed">15294895</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen JL, Long AM, Schultz SC (1997) Structure of the RNA-dependent RNA polymerase of poliovirus. Structure 5: 1109&#x2013;1122.</Citation><ArticleIdList><ArticleId IdType="pubmed">9309225</ArticleId></ArticleIdList></Reference><Reference><Citation>Love RA, Maegley KA, Yu X, Ferre RA, Lingardo LK, Diehl W, Parge HE, Dragovich PS, Fuhrman SA (2004) The crystal structure of the RNA-dependent RNA polymerase from human rhinovirus: a dual function target for common cold antiviral therapy. Structure 12: 1533&#x2013;1544.</Citation><ArticleIdList><ArticleId IdType="pubmed">15296746</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AA, Peersen OB (2004) Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase. EMBO J 23: 3462&#x2013;3471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC516629</ArticleId><ArticleId IdType="pubmed">15306852</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Lou Z, Miao Y, Yu Y, Dong H, Peng W, Bartlam M, Li X, Rao Z (2010) Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China. Protein Cell 1: 491&#x2013;500. 10.1007/s13238-010-0061-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-010-0061-7</ArticleId><ArticleId IdType="pmc">PMC4875138</ArticleId><ArticleId IdType="pubmed">21203964</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagnola G, Weygandt M, Scoggin K, Peersen O (2008) Crystal structure of coxsackievirus B3 3Dpol highlights the functional importance of residue 5 in picornavirus polymerases. J Virol 82: 9458&#x2013;9464. 10.1128/JVI.00647-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00647-08</ArticleId><ArticleId IdType="pmc">PMC2546958</ArticleId><ArticleId IdType="pubmed">18632862</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruez A, Selisko B, Roberts M, Bricogne G, Bussetta C, Jabafi I, Coutard B, De Palma AM, Neyts J, Canard B (2008) The crystal structure of coxsackievirus B3 RNA-dependent RNA polymerase in complex with its protein primer VPg confirms the existence of a second VPg binding site on Picornaviridae polymerases. J Virol 82: 9577&#x2013;9590. 10.1128/JVI.00631-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00631-08</ArticleId><ArticleId IdType="pmc">PMC2546979</ArticleId><ArticleId IdType="pubmed">18632861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Orta C, Arias A, Escarmis C, Verdaguer N (2006) A comparison of viral RNA-dependent RNA polymerases. Curr Opin Struct Biol 16: 27&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">16364629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Orta C, Agudo R, Domingo E, Verdaguer N (2009) Structural insights into replication initiation and elongation processes by the FMDV RNA-dependent RNA polymerase. Curr Opin Struct Biol 19: 752&#x2013;758. 10.1016/j.sbi.2009.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2009.10.016</ArticleId><ArticleId IdType="pubmed">19914060</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, Cameron CE, Andino R (2001) RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 98: 6895&#x2013;6900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34449</ArticleId><ArticleId IdType="pubmed">11371613</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy JA, Wells JA (2004) Searching for new allosteric sites in enzymes. Curr Opin Struct Biol 14: 706&#x2013;715.</Citation><ArticleIdList><ArticleId IdType="pubmed">15582395</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagnola G, Gong P, Peersen OB (2011) High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. Antiviral Res 91: 241&#x2013;251. 10.1016/j.antiviral.2011.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.06.006</ArticleId><ArticleId IdType="pmc">PMC3159743</ArticleId><ArticleId IdType="pubmed">21722674</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TC, Chang HY, Lin PF, Chern JH, Hsu JT, Chang CY, Shih SR (2009) Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71. Antimicrob Agents Chemother 53: 2740&#x2013;2747. 10.1128/AAC.00101-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00101-09</ArticleId><ArticleId IdType="pmc">PMC2704669</ArticleId><ArticleId IdType="pubmed">19414569</ArticleId></ArticleIdList></Reference><Reference><Citation>Durk RC, Singh K, Cornelison CA, Rai DK, Matzek KB, Leslie MD, Schafer E, Marchand B, Adedeji A, Michailidis E, Dorst CA, Moran J, Pautler C, Rodriguez LL, McIntosh MA, Rieder E, Sarafianos SG (2010) Inhibitors of foot and mouth disease virus targeting a novel pocket of the RNA-dependent RNA polymerase. PLoS One 5: e15049 10.1371/journal.pone.0015049</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015049</ArticleId><ArticleId IdType="pmc">PMC3006429</ArticleId><ArticleId IdType="pubmed">21203539</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, Gowen BB, Julander JG, Morrey JD (2009) T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res 82: 95&#x2013;102. 10.1016/j.antiviral.2009.02.198</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.02.198</ArticleId><ArticleId IdType="pmc">PMC7127082</ArticleId><ArticleId IdType="pubmed">19428599</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison DN, Gazina EV, Purcell DF, Anderson DA, Petrou S (2008) Amiloride derivatives inhibit coxsackievirus B3 RNA replication. J Virol 82: 1465&#x2013;1473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2224459</ArticleId><ArticleId IdType="pubmed">18032495</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung HC, Chen TC, Fang MY, Yen KJ, Shih SR, Hsu JT, Tseng CP (2010) Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. J Antimicrob Chemother 65: 676&#x2013;683. 10.1093/jac/dkp502</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkp502</ArticleId><ArticleId IdType="pmc">PMC7110181</ArticleId><ArticleId IdType="pubmed">20089540</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez PL, Carrasco L (1992) Gliotoxin: inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol. J Virol 66: 1971&#x2013;1976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC288985</ArticleId><ArticleId IdType="pubmed">1372367</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazina EV, Smidansky ED, Holien JK, Harrison DN, Cromer BA, Arnold JJ, Parker MW, Cameron CE, Petrou S (2011) Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase. J Virol 85: 10364&#x2013;10374. 10.1128/JVI.05022-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05022-11</ArticleId><ArticleId IdType="pmc">PMC3196452</ArticleId><ArticleId IdType="pubmed">21795353</ArticleId></ArticleIdList></Reference><Reference><Citation>Purstinger G, De Palma AM, Zimmerhofer G, Huber S, Ladurner S, Neyts J (2008) Synthesis and anti-CVB 3 evaluation of substituted 5-nitro-2-phenoxybenzonitriles. Bioorg Med Chem Lett 18: 5123&#x2013;5125. 10.1016/j.bmcl.2008.07.099</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2008.07.099</ArticleId><ArticleId IdType="pubmed">18710805</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kuppeveld FJ, Galama JM, Zoll J, Melchers WJ (1995) Genetic analysis of a hydrophobic domain of coxsackie B3 virus protein 2B: a moderate degree of hydrophobicity is required for a cis-acting function in viral RNA synthesis. J Virol 69: 7782&#x2013;7790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189721</ArticleId><ArticleId IdType="pubmed">7494289</ArticleId></ArticleIdList></Reference><Reference><Citation>Etchison D, Milburn SC, Edery I, Sonenberg N, Hershey JW (1982) Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem 257: 14806&#x2013;14810.</Citation><ArticleIdList><ArticleId IdType="pubmed">6294080</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma AM, Heggermont W, Lanke K, Coutard B, Bergmann M, Monforte AM, Canard B, De Clercq E, Chimirri A, Purstinger G, Rohayem J, van Kuppeveld F, Neyts J (2008) The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C. J Virol 82: 4720&#x2013;4730. 10.1128/JVI.01338-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01338-07</ArticleId><ArticleId IdType="pmc">PMC2346740</ArticleId><ArticleId IdType="pubmed">18337578</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma AM, Thibaut HJ, van der Linden L, Lanke K, Heggermont W, Ireland S, Andrews R, Arimilli M, Al-Tel TH, De Clercq E, van Kuppeveld F, Neyts J (2009) Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. Antimicrob Agents Chemother 53: 1850&#x2013;1857. 10.1128/AAC.00934-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00934-08</ArticleId><ArticleId IdType="pmc">PMC2681499</ArticleId><ArticleId IdType="pubmed">19237651</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaut HJ, van der Linden L, Jiang P, Thys B, Canela MD, Aguado L, Rombaut B, Wimmer E, Paul A, Perez-Perez MJ, van Kuppeveld FJ, Neyts J (2014) Binding of glutathione to enterovirus capsids is essential for virion morphogenesis. PLoS Pathog 10: e1004039 10.1371/journal.ppat.1004039</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004039</ArticleId><ArticleId IdType="pmc">PMC3983060</ArticleId><ArticleId IdType="pubmed">24722756</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives-Adrian L, Lujan C, Oliva B, van der LL, Selisko B, Coutard B, Canard B, van Kuppeveld FJ, Ferrer-Orta C, Verdaguer N (2014) The crystal structure of a cardiovirus RNA-dependent RNA polymerase reveals an unusual conformation of the polymerase active site. J Virol 88: 5595&#x2013;5607. 10.1128/JVI.03502-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03502-13</ArticleId><ArticleId IdType="pmc">PMC4019119</ArticleId><ArticleId IdType="pubmed">24600002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Orta C, Arias A, Perez-Luque R, Escarmis C, Domingo E, Verdaguer N (2007) Sequential structures provide insights into the fidelity of RNA replication. Proc Natl Acad Sci U S A 104: 9463&#x2013;9468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1890517</ArticleId><ArticleId IdType="pubmed">17517631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kortus MG, Kempf BJ, Haworth KG, Barton DJ, Peersen OB (2012) A template RNA entry channel in the fingers domain of the poliovirus polymerase. J Mol Biol 417: 263&#x2013;278. 10.1016/j.jmb.2012.01.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2012.01.049</ArticleId><ArticleId IdType="pmc">PMC3325025</ArticleId><ArticleId IdType="pubmed">22321798</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestas SP, Sholders AJ, Peersen OB (2007) A fluorescence polarization-based screening assay for nucleic acid polymerase elongation activity. Anal Biochem 365: 194&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2713175</ArticleId><ArticleId IdType="pubmed">17475199</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold JJ, Cameron CE (2000) Poliovirus RNA-dependent RNA polymerase (3D(pol)). Assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/sub). J Biol Chem 275: 5329&#x2013;5336.</Citation><ArticleIdList><ArticleId IdType="pubmed">10681506</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias A, Arnold JJ, Sierra M, Smidansky ED, Domingo E, Cameron CE (2008) Determinants of RNA-dependent RNA polymerase (in)fidelity revealed by kinetic analysis of the polymerase encoded by a foot-and-mouth disease virus mutant with reduced sensitivity to ribavirin. J Virol 82: 12346&#x2013;12355. 10.1128/JVI.01297-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01297-08</ArticleId><ArticleId IdType="pmc">PMC2593321</ArticleId><ArticleId IdType="pubmed">18829745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong P, Peersen OB (2010) Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A 107: 22505&#x2013;22510. 10.1073/pnas.1007626107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1007626107</ArticleId><ArticleId IdType="pmc">PMC3012486</ArticleId><ArticleId IdType="pubmed">21148772</ArticleId></ArticleIdList></Reference><Reference><Citation>Garriga D, Navarro A, Querol-Audi J, Abaitua F, Rodriguez JF, Verdaguer N (2007) Activation mechanism of a noncanonical RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A 104: 20540&#x2013;20545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2154467</ArticleId><ArticleId IdType="pubmed">18077388</ArticleId></ArticleIdList></Reference><Reference><Citation>Garriga D, Ferrer-Orta C, Querol-Audi J, Oliva B, Verdaguer N (2013) Role of Motif B Loop in Allosteric Regulation of RNA-Dependent RNA Polymerization Activity. J Mol Biol.</Citation><ArticleIdList><ArticleId IdType="pubmed">23542342</ArticleId></ArticleIdList></Reference><Reference><Citation>Niyomrattanakit P, Chen YL, Dong H, Yin Z, Qing M, Glickman JF, Lin K, Mueller D, Voshol H, Lim JY, Nilar S, Keller TH, Shi PY (2010) Inhibition of dengue virus polymerase by blocking of the RNA tunnel. J Virol 84: 5678&#x2013;5686. 10.1128/JVI.02451-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02451-09</ArticleId><ArticleId IdType="pmc">PMC2876596</ArticleId><ArticleId IdType="pubmed">20237086</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LZ, Kenyon GL, Johnson KA (2004) Novel mechanism of inhibition of HIV-1 reverse transcriptase by a new non-nucleoside analog, KM-1. J Biol Chem 279: 38424&#x2013;38432.</Citation><ArticleIdList><ArticleId IdType="pubmed">15231830</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoll J, Galama JM, van Kuppeveld FJ, Melchers WJ (1996) Mengovirus leader is involved in the inhibition of host cell protein synthesis. J Virol 70: 4948&#x2013;4952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190446</ArticleId><ArticleId IdType="pubmed">8763999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E, Duijsings D, Notebaart RA, Melchers WJ, van Kuppeveld FJ (2005) A proline-rich region in the coxsackievirus 3A protein is required for the protein to inhibit endoplasmic reticulum-to-golgi transport. J Virol 79: 5163&#x2013;5173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1069528</ArticleId><ArticleId IdType="pubmed">15795300</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke GM, Palmenberg AC (1989) Cloning and synthesis of infectious cardiovirus RNAs containing short, discrete poly(C) tracts. J Virol 63: 1822&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC248463</ArticleId><ArticleId IdType="pubmed">2538661</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoll J, Erkens HS, Lanke K, Verduyn LF, Melchers WJ, Schoondermark-van de Ven E, Roivainen M, Galama JM, van Kuppeveld FJ (2009) Saffold virus, a human Theiler's-like cardiovirus, is ubiquitous and causes infection early in life. PLoS Pathog 5: e1000416 10.1371/journal.ppat.1000416</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000416</ArticleId><ArticleId IdType="pmc">PMC2670511</ArticleId><ArticleId IdType="pubmed">19412527</ArticleId></ArticleIdList></Reference><Reference><Citation>Goris NE, Eble PL, de Jong MC, De Clercq K (2009) Quantification of foot-and-mouth disease virus transmission rates using published data. ALTEX 26: 52&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">19326033</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H (2012) A simple method of estimating the fifty per cent endpoints. Am J Hyg 27: 493&#x2013;497.</Citation></Reference><Reference><Citation>Aminev AG, Amineva SP, Palmenberg AC (2003) Encephalomyocarditis virus (EMCV) proteins 2A and 3BCD localize to nuclei and inhibit cellular mRNA transcription but not rRNA transcription. Virus Res 95: 59&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">12921996</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA, Feng Q, Nikovics K, Jackson CL, Ehrenfeld E (2008) A critical role of a cellular membrane traffic protein in poliovirus RNA replication. PLoS Pathog 4: e1000216 10.1371/journal.ppat.1000216</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000216</ArticleId><ArticleId IdType="pmc">PMC2581890</ArticleId><ArticleId IdType="pubmed">19023417</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ooij MJM (2007) Biological characterization of a Coxsackie B3 virus revertant exhibiting a thermophilic phenotype. PhD thesis. Radboud University Nijmegen. Available: http://repository.ubn.ru.nl/bitstream/handle/2066/30016/30016.pdf?sequence=1.</Citation></Reference><Reference><Citation>Jabafi I, Selisko B, Coutard B, De Palma AM, Neyts J, Egloff MP, Grisel S, Dalle K, Campanacci V, Spinelli S, Cambillau C, Canard B, Gruez A (2007) Improved crystallization of the coxsackievirus B3 RNA-dependent RNA polymerase. Acta Crystallogr Sect F Struct Biol Cryst Commun 63: 495&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335076</ArticleId><ArticleId IdType="pubmed">17554171</ArticleId></ArticleIdList></Reference><Reference><Citation>Selisko B, Dutartre H, Guillemot JC, Debarnot C, Benarroch D, Khromykh A, Despres P, Egloff MP, Canard B (2006) Comparative mechanistic studies of de novo RNA synthesis by flavivirus RNA-dependent RNA polymerases. Virology 351: 145&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">16631221</ArticleId></ArticleIdList></Reference><Reference><Citation>Lantez V, Dalle K, Charrel R, Baronti C, Canard B, Coutard B (2011) Comparative production analysis of three phlebovirus nucleoproteins under denaturing or non-denaturing conditions for crystallographic studies. PLoS Negl Trop Dis 5: e936 10.1371/journal.pntd.0000936</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000936</ArticleId><ArticleId IdType="pmc">PMC3014985</ArticleId><ArticleId IdType="pubmed">21245924</ArticleId></ArticleIdList></Reference><Reference><Citation>Leslie AGW, Powell HR (2007) Processing Diffraction Data with Mosflm In: Read R, Sussman JL, editors. Evolving Methods for Macromolecular Crystallography. Dordrecht, the Netherlands: Springer; pp. 41&#x2013;51.</Citation></Reference><Reference><Citation>Potterton E, Briggs P, Turkenburg M, Dodson E (2003) A graphical user interface to the CCP4 program suite. Acta Crystallogr D Biol Crystallogr 59: 1131&#x2013;1137.</Citation><ArticleIdList><ArticleId IdType="pubmed">12832755</ArticleId></ArticleIdList></Reference><Reference><Citation>Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53: 240&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">15299926</ArticleId></ArticleIdList></Reference><Reference><Citation>Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F, Vagin AA (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr 67: 355&#x2013;367. 10.1107/S0907444911001314</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444911001314</ArticleId><ArticleId IdType="pmc">PMC3069751</ArticleId><ArticleId IdType="pubmed">21460454</ArticleId></ArticleIdList></Reference><Reference><Citation>Smart OS, Womack TO, Sharff A, Flensburg C, Keller P, Paciorek W, Vonrhein C, Bricogne G (2011) Grade, version 1.1.0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3069744</ArticleId><ArticleId IdType="pubmed">21460447</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126&#x2013;2132.</Citation><ArticleIdList><ArticleId IdType="pubmed">15572765</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>